ARCHIVES

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

Two Studies Suggest Positive HPV Status Can Indicate Improved Patient Outcomes

February 28, 2014

Funding Opportunities: NCI’s RAPID Program; RFA, Pas Avilable

May 14, 1999

What Research Will, Will Not Be Funded At Various Levels – FY 1997 ZBB

October 14, 1977

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008

Community Hospital Oncology Program RFP Deadline Moved Back to Sept. 5

June 22, 1979

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014